Voice AI sold to hospitals often sounds fluent and demonstrates little. Tucuvi makes the opposite case: its calling agent carried a medical device certification before anyone marketed it as a productivity shortcut.
Microsoft’s Pegasus program opens Azure’s door
Selection for the Microsoft for Startups Pegasus Program is the Madrid company’s new credential. Startups admitted to it get Azure AI models, enterprise-grade security and privacy, and go-to-market help. Tom Davis, who serves as general manager of Microsoft for Startups, described the aim as helping companies build fast, scale smart and sell more through the broader Microsoft ecosystem.
LOLA, the clinical voice agent that handles inbound and outbound patient calls, sits alongside Tucuvi Health Manager. Protocols, escalation criteria and follow-up coordination are all configured in that second layer.
Already deployed in 80-plus settings
Deployment, by the company’s account, reaches over 80 health organizations and more than 50 clinical workflows. Transitional care management, chronic care check-ins, medication adherence, refills and scheduling are among them, and EHRs, CRM and call center systems plug in as well.
Maria Gonzalez Manso, chief executive and co-founder, says buyers seldom open with whether an agent sounds natural. What they press on, she said, is who owns the clinical protocol, how the system behaves when a patient raises something that only a clinician can resolve, and whether that behavior holds steady across calls.
In the European Union, Tucuvi holds Class IIb Software as a Medical Device certification. Few patient-facing voice platforms reach that level of clinical validation. Selling the distinction into US health systems is the company’s core argument.
